Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Perfusing chemotherapy by percutaneous lung puncture in the treatment of extensive drug resistant pulmonary tuberculosis.

Yang SH, Zhan P, Sun M, Zhang YP, Ma NL.

J Thorac Dis. 2012 Dec;4(6):624-8. doi: 10.3978/j.issn.2072-1439.2012.06.09.

2.

Extensively drug-resistant tuberculosis in the United States, 1993-2007.

Shah NS, Pratt R, Armstrong L, Robison V, Castro KG, Cegielski JP.

JAMA. 2008 Nov 12;300(18):2153-60. doi: 10.1001/jama.300.18.2153.

PMID:
19001626
3.

Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Park SK, Kim JH, Kang H, Cho JS, Smego RA Jr.

Int J Infect Dis. 2009 Mar;13(2):170-5. doi: 10.1016/j.ijid.2008.06.001. Epub 2008 Sep 2.

4.

Radiological findings of extensively drug-resistant pulmonary tuberculosis in non-AIDS adults: comparisons with findings of multidrug-resistant and drug-sensitive tuberculosis.

Cha J, Lee HY, Lee KS, Koh WJ, Kwon OJ, Yi CA, Kim TS, Chung MJ.

Korean J Radiol. 2009 May-Jun;10(3):207-16. doi: 10.3348/kjr.2009.10.3.207. Epub 2009 Apr 22.

5.

Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis.

Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, van Soolingen D, Jensen P, Bayona J.

Lancet. 2010 May 22;375(9728):1830-43. doi: 10.1016/S0140-6736(10)60410-2.

PMID:
20488523
6.

Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.

Prasad R.

Indian J Tuberc. 2010 Oct;57(4):180-91. Review.

PMID:
21141336
7.

Characteristics and treatment outcomes of patients with MDR and XDR tuberculosis in a TB referral hospital in Beijing: a 13-year experience.

Liu CH, Li L, Chen Z, Wang Q, Hu YL, Zhu B, Woo PC.

PLoS One. 2011 Apr 29;6(4):e19399. doi: 10.1371/journal.pone.0019399.

8.

Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.

Centers for Disease Control and Prevention (CDC)..

MMWR Recomm Rep. 2009 Feb 13;58(RR-3):1-43.

9.

Multidrug and extensively drug-resistant tuberculosis management: Evidences and controversies.

Prasad R.

Lung India. 2012 Apr;29(2):154-9. doi: 10.4103/0970-2113.95321.

10.

Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.

Vella V, Racalbuto V, Guerra R, Marra C, Moll A, Mhlanga Z, Maluleke M, Mhlope H, Margot B, Friedland G, Shah NS, Gandhi NR.

Int J Tuberc Lung Dis. 2011 Sep;15(9):1170-5, i. doi: 10.5588/ijtld.10.0781.

PMID:
21943840
11.

Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.

Cohen KA, Abeel T, Manson McGuire A, Desjardins CA, Munsamy V, Shea TP, Walker BJ, Bantubani N, Almeida DV, Alvarado L, Chapman SB, Mvelase NR, Duffy EY, Fitzgerald MG, Govender P, Gujja S, Hamilton S, Howarth C, Larimer JD, Maharaj K, Pearson MD, Priest ME, Zeng Q, Padayatchi N, Grosset J, Young SK, Wortman J, Mlisana KP, O'Donnell MR, Birren BW, Bishai WR, Pym AS, Earl AM.

PLoS Med. 2015 Sep 29;12(9):e1001880. doi: 10.1371/journal.pmed.1001880. eCollection 2015 Sep.

12.

Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis.

Kim DH, Kim HJ, Park SK, Kong SJ, Kim YS, Kim TH, Kim EK, Lee KM, Lee SS, Park JS, Koh WJ, Lee CH, Shim TS.

Am J Respir Crit Care Med. 2010 Jul 1;182(1):113-9. doi: 10.1164/rccm.200911-1656OC. Epub 2010 Mar 11.

PMID:
20224066
13.

Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Choi YS, Kim K, Kim J, Shim YM, Koh WJ.

Clin Infect Dis. 2008 Aug 15;47(4):496-502. doi: 10.1086/590005.

PMID:
18611154
14.

Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community.

Andrews JR, Shah NS, Weissman D, Moll AP, Friedland G, Gandhi NR.

PLoS One. 2010 Dec 29;5(12):e15735. doi: 10.1371/journal.pone.0015735.

15.

Development of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatment.

Shin SS, Keshavjee S, Gelmanova IY, Atwood S, Franke MF, Mishustin SP, Strelis AK, Andreev YG, Pasechnikov AD, Barnashov A, Tonkel TP, Cohen T.

Am J Respir Crit Care Med. 2010 Aug 1;182(3):426-32. doi: 10.1164/rccm.200911-1768OC. Epub 2010 Apr 22.

16.

Multidrug-resistant and extensively drug-resistant tuberculosis in multi-ethnic region, Xinjiang Uygur Autonomous Region, China.

Qi YC, Ma MJ, Li DJ, Chen MJ, Lu QB, Li XJ, Li JL, Liu W, Cao WC.

PLoS One. 2012;7(2):e32103. doi: 10.1371/journal.pone.0032103. Epub 2012 Feb 22.

17.

Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005-2007.

Marks SM, Flood J, Seaworth B, Hirsch-Moverman Y, Armstrong L, Mase S, Salcedo K, Oh P, Graviss EA, Colson PW, Armitige L, Revuelta M, Sheeran K; TB Epidemiologic Studies Consortium..

Emerg Infect Dis. 2014 May;20(5):812-21. doi: 10.3201/eid2005.131037.

18.

Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.

Hu Y, Mathema B, Zhao Q, Zheng X, Li D, Jiang W, Wang W, Xu B.

Tuberculosis (Edinb). 2016 Mar;97:18-25. doi: 10.1016/j.tube.2015.11.007. Epub 2015 Dec 23.

PMID:
26980491
19.

Computed tomography features of extensively drug-resistant pulmonary tuberculosis in non-HIV-infected patients.

Lee ES, Park CM, Goo JM, Yim JJ, Kim HR, Lee HJ, Lee IS, Im JG.

J Comput Assist Tomogr. 2010 Jul;34(4):559-63. doi: 10.1097/RCT.0b013e3181d472bc.

PMID:
20657225
20.

Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China.

Yuan X, Zhang T, Kawakami K, Zhu J, Zheng W, Li H, Deng G, Tu S, Liu W.

BMC Infect Dis. 2013 Jul 12;13:315. doi: 10.1186/1471-2334-13-315.

Supplemental Content

Support Center